Geneva Partners, LLC Mckesson Corp Transaction History

Geneva Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$518.81 - $607.81 $93,385 - $109,405	-180 Reduced 2.1%	8,390 $4.9 Million
Q1 2024 Apr 30, 2024	BUY	$473.42 - $539.26 $4,734 - $5,392	10 Added 0.12%	8,570 $4.6 Million
Q4 2023 Jan 31, 2024	SELL	$437.42 - $470.64 $826,723 - $889,509	-1,890 Reduced 18.09%	8,560 $3.96 Million
Q3 2023 Oct 25, 2023	BUY	$402.4 - $446.42 $2.89 Million - $3.21 Million	7,187 Added 220.26%	10,450 $4.54 Million
Q2 2023 Aug 03, 2023	BUY	$354.01 - $427.31 $1.16 Million - $1.39 Million	3,263 New	3,263 $1.39 Million
Q4 2022 Jan 23, 2023	SELL	$346.68 - $397.58 $286,011 - $328,003	-825 Reduced 13.03%	5,508 $0
Q3 2022 Oct 31, 2022	BUY	$321.25 - $373.84 $2.03 Million - $2.37 Million	6,333 New	6,333 $2.15 Million

1,690

108M

1.66M

968K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $83.2B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Geneva Partners, LLC with notifications on news.